Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues

Area of Science:

• Endocrinology and Molecular Medicine
• Pharmacology

Background:

• The glucocorticoid receptor (GR) is a key target for treating severe inflammation.
• Glucocorticoid excess causes well-known metabolic issues like hyperglycemia and obesity.
• Understanding molecular mediators of GR action is crucial for safer therapies.

Purpose of the Study:

• To review recent discoveries in tissue-selective modulators of glucocorticoid signaling.
• To highlight molecular effects of GR activation in specific tissues.
• To identify strategies for improving therapeutic efficacy while reducing side effects.

Main Methods:

• Literature review of recent research on glucocorticoid signaling.
• Focus on molecular mechanisms and tissue-specific effects.
• Emphasis on modulators impacting liver, adipose tissue, muscle, and pancreas.

Main Results:

• Identification of specific protein mediators influencing glucocorticoid response.
• Elucidation of downstream molecular effects of GR activation in key metabolic tissues.
• Understanding how these mediators contribute to unwanted side effects.

Conclusions:

• Tissue-selective modulators offer potential for tailored GR therapies.
• Targeting these modulators may improve treatment efficacy for inflammatory conditions.
• Minimizing metabolic side effects is achievable through a deeper understanding of GR signaling pathways.